Otsuka Says Wockhardt's ANDA Infringes Abilify Patent
Otsuka Pharmaceutical Co. Ltd. sued Wockhardt USA LLC in New Jersey federal court Thursday for infringing its patent for Abilify, after the generics maker submitted an abbreviated new drug application for...To view the full article, register now.
Already a subscriber? Click here to view full article